SIMABS NV has developed a unique platform for fast, flexible and cost effective development and manufacturing  of monoclonal antibodies. We deliver total solutions for your development and manufacturing by means of a new and unique manufacturing platform based on continuous bioprocessing. This platform allows us to produce several complex antibodies (monoclonal, bispecific, multivalent,…) in a range from milligrams to kilograms for biopharmaceutical companies. This platform will enable personalised medicine to become an affordable reality.

We are a one stop shop with a lean and customer oriented project management approach. SIMABS offers additional services like:
•	Cell line development
•	USP/DSP development
•	Analytical and formulation development
•	Quality Management
•	Validation
•	Project Management
•	Technology Transfer to GMP
•	Regulatory Affairs
•	Clinical Research
Contact us to learn more about our pharmaceutical contract development and manufacturing capabilities.


simAbs

Org chart

Teams

Offices